| pubmed-article:17482691 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:17482691 | lifeskim:mentions | umls-concept:C0003009 | lld:lifeskim |
| pubmed-article:17482691 | lifeskim:mentions | umls-concept:C0529330 | lld:lifeskim |
| pubmed-article:17482691 | lifeskim:mentions | umls-concept:C0021107 | lld:lifeskim |
| pubmed-article:17482691 | lifeskim:mentions | umls-concept:C0038257 | lld:lifeskim |
| pubmed-article:17482691 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
| pubmed-article:17482691 | lifeskim:mentions | umls-concept:C1522492 | lld:lifeskim |
| pubmed-article:17482691 | lifeskim:mentions | umls-concept:C0332206 | lld:lifeskim |
| pubmed-article:17482691 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:17482691 | pubmed:dateCreated | 2008-4-29 | lld:pubmed |
| pubmed-article:17482691 | pubmed:abstractText | To evaluate the effect of supraphysiological levels of angiotensin II and selective angiotensin II type 1 receptor (AT1-receptor) blockade on neointimal formation and systemic endothelial function after stent implantation in the rat abdominal aorta. | lld:pubmed |
| pubmed-article:17482691 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17482691 | pubmed:language | eng | lld:pubmed |
| pubmed-article:17482691 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17482691 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:17482691 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17482691 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17482691 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17482691 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:17482691 | pubmed:month | May | lld:pubmed |
| pubmed-article:17482691 | pubmed:issn | 1874-1754 | lld:pubmed |
| pubmed-article:17482691 | pubmed:author | pubmed-author:van... | lld:pubmed |
| pubmed-article:17482691 | pubmed:author | pubmed-author:RoksAnton J... | lld:pubmed |
| pubmed-article:17482691 | pubmed:author | pubmed-author:ZijlstraFelix... | lld:pubmed |
| pubmed-article:17482691 | pubmed:author | pubmed-author:BuikemaHendri... | lld:pubmed |
| pubmed-article:17482691 | pubmed:author | pubmed-author:van der... | lld:pubmed |
| pubmed-article:17482691 | pubmed:author | pubmed-author:de SmetBart... | lld:pubmed |
| pubmed-article:17482691 | pubmed:author | pubmed-author:GroenewegenHe... | lld:pubmed |
| pubmed-article:17482691 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:17482691 | pubmed:day | 23 | lld:pubmed |
| pubmed-article:17482691 | pubmed:volume | 126 | lld:pubmed |
| pubmed-article:17482691 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:17482691 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:17482691 | pubmed:pagination | 209-15 | lld:pubmed |
| pubmed-article:17482691 | pubmed:dateRevised | 2009-4-27 | lld:pubmed |
| pubmed-article:17482691 | pubmed:meshHeading | pubmed-meshheading:17482691... | lld:pubmed |
| pubmed-article:17482691 | pubmed:meshHeading | pubmed-meshheading:17482691... | lld:pubmed |
| pubmed-article:17482691 | pubmed:meshHeading | pubmed-meshheading:17482691... | lld:pubmed |
| pubmed-article:17482691 | pubmed:meshHeading | pubmed-meshheading:17482691... | lld:pubmed |
| pubmed-article:17482691 | pubmed:meshHeading | pubmed-meshheading:17482691... | lld:pubmed |
| pubmed-article:17482691 | pubmed:meshHeading | pubmed-meshheading:17482691... | lld:pubmed |
| pubmed-article:17482691 | pubmed:meshHeading | pubmed-meshheading:17482691... | lld:pubmed |
| pubmed-article:17482691 | pubmed:meshHeading | pubmed-meshheading:17482691... | lld:pubmed |
| pubmed-article:17482691 | pubmed:meshHeading | pubmed-meshheading:17482691... | lld:pubmed |
| pubmed-article:17482691 | pubmed:meshHeading | pubmed-meshheading:17482691... | lld:pubmed |
| pubmed-article:17482691 | pubmed:year | 2008 | lld:pubmed |
| pubmed-article:17482691 | pubmed:articleTitle | Effects of angiotensin II and angiotensin II type 1 receptor blockade on neointimal formation after stent implantation. | lld:pubmed |
| pubmed-article:17482691 | pubmed:affiliation | Department of Clinical Pharmacology, University Medical Center Groningen, University of Groningen, The Netherlands. r.groenewegen@med.umcg.nl | lld:pubmed |
| pubmed-article:17482691 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:17482691 | pubmed:publicationType | Comparative Study | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17482691 | lld:pubmed |
